A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Transplantation of hematopoetic stem cells obtained from any source (bone-marrow, peripheral blood, umblical cord blood) is a treatment method used not only for hematopoietic system diseases but also for metabolic and immunologic disorders. Patients who undergo hematopoetic stem cell transplantation (HST) also carry higher risk in terms of transplantation-related mortality and morbidity developing due to immune mechanisms, toxicity due to medications used in preparative regimens, and longdoi:10.5606/fng.transplantasyon.2016.016 fatcat:whcv2wfix5bdnipanpyccqcc4a